DHEA-S, decoded.

The editorial TLDR.

What DHEA-S actually is.

DHEA is a steroid hormone produced primarily by the zona reticularis of the adrenal cortex — the outer layer of the adrenal glands, which sit on top of each kidney. A small amount is also produced by the ovaries. Once secreted, DHEA is rapidly sulfated by the liver and adrenal into DHEA-sulfate (DHEA-S), the form that circulates in the highest concentrations and the form that's measured in blood. DHEA-S has a much longer half-life and far less diurnal variation than DHEA itself, which is why it's the preferred test.

DHEA and DHEA-S sit at a branch point. The body can convert DHEA downstream into androstenedione and then into testosterone (which can in turn aromatize into estradiol), or into the weaker estrogen estrone. Roughly half of a premenopausal woman's circulating testosterone comes — directly or indirectly — from this adrenal precursor pathway. After menopause, when ovarian production has largely stopped, the proportion rises further: DHEA and its downstream products become the dominant source of sex steroid activity.

"DHEA-S is the body's slow, steady supply. It's the hormonal reservoir most women never hear about — until it's running low."

DHEA-S peaks in the early-to-mid twenties and declines gradually thereafter — by the time many women reach their seventies, levels are roughly 10–20% of their reproductive-age peak. This decline is sometimes referred to in the literature as "adrenopause," and it tracks parallel to (but distinct from) the menopause transition.

Standard U.S. labs measure DHEA-S with an immunoassay. The results vary modestly by laboratory and assay, and reference ranges drop sharply with age — a value that's perfectly normal at 50 would be unusually low at 25.

Why DHEA-S matters for women.

DHEA-S is one of those biomarkers that almost never makes it onto a standard U.S. annual physical — and yet shows up in three clinical conversations that matter a great deal for women's health.

PCOS and androgen excess. Roughly one in ten U.S. women of reproductive age has PCOS, and in approximately 20–30% of those cases, DHEA-S is elevated alongside (or instead of) total or free testosterone. This is the "adrenal-predominant" PCOS subtype, where the adrenal contribution to androgen excess outweighs the ovarian. Distinguishing it matters clinically — the workup is slightly different, and so are the treatment conversations.

Perimenopause and adrenopause. As ovarian estrogen and testosterone fall through the late thirties, forties and fifties, adrenal androgens take on a larger proportional role. A woman with already-low DHEA-S entering perimenopause may experience the transition more sharply — more fatigue, more libido and mood flatness, more sense of "running on empty" — than a woman whose adrenal reservoir is fuller. Whether DHEA replacement is clinically useful in this context is still debated; the question is increasingly part of the women's-health conversation.

Chronic stress, fatigue and HPA-axis patterns. The adrenal glands respond to chronic stress by sustaining high cortisol output, often at the expense of DHEA and DHEA-S. In some women with long-running burnout patterns, the result is a low DHEA-S alongside a flattened cortisol curve. This isn't a diagnosis on its own — "adrenal fatigue" is not a recognized medical condition — but the pattern is real, and DHEA-S is one of the data points clinicians and integrative practitioners look at.

Adrenal insufficiency. Less commonly, very low DHEA-S is a clue toward primary adrenal insufficiency (Addison's disease), particularly when paired with low morning cortisol, fatigue, low blood pressure and salt cravings. This is a clinical workup, not a self-interpretable lab.

Rare androgen-secreting tumors. Very high DHEA-S — particularly above 700 µg/dL in a woman without other PCOS features — can be a flag for an adrenal tumor and is worth a workup with a qualified provider.

What the ranges generally mean.

Most U.S. labs report DHEA-S in µg/dL. Reference ranges decline sharply with age; the broad shape below is for premenopausal adult women in their twenties to mid-thirties.

Illustrative ranges, not diagnostic. Reference ranges drop substantially with age and vary by laboratory. Always discuss your specific result with a qualified healthcare provider.

What may drive DHEA-S low or high.

The patterns below come up most often when DHEA-S reads outside the comfortable zone for a woman's age.

What may drive DHEA-S low.

• Age. The single biggest driver. Levels decline steadily from the mid-twenties onward.
• Chronic stress / HPA-axis suppression. Sustained high cortisol output is associated with reduced adrenal DHEA production in some women — the pattern often called adrenal "down-shift" in functional medicine.
• Primary adrenal insufficiency (Addison's). A clinical condition with low cortisol and low DHEA-S together. Rare but important to rule out with significant fatigue, low blood pressure and electrolyte changes.
• Long-term glucocorticoid use. Oral, inhaled or topical corticosteroids can suppress adrenal output of DHEA over time.
• Combined oral contraception. Some studies show modest reductions in DHEA-S on combined OCPs, though the effect is smaller than on free testosterone.
• Pituitary patterns (hypopituitarism). Less common, but worth ruling out with very low DHEA-S alongside other low pituitary-driven hormones.
• Severe acute illness or malnutrition. Significant systemic stress can transiently suppress DHEA-S production.

What may drive DHEA-S elevated.

• Polycystic ovary syndrome (adrenal-predominant). Roughly 20–30% of women with PCOS have elevated DHEA-S as part of the androgen-excess pattern.
• Non-classic congenital adrenal hyperplasia (NCAH). A genetic adrenal pattern that produces an androgen-excess picture similar to PCOS. Distinguished with a 17-hydroxyprogesterone test.
• Cushing's syndrome. Excess cortisol patterns sometimes co-occur with elevated adrenal androgens.
• Adrenal tumors. Rare but clinically important — particularly with DHEA-S values above 700 µg/dL, rapid onset of androgen symptoms or other red flags.
• DHEA supplementation. Available over the counter in the U.S. Many women take it for fatigue, libido or perimenopause symptoms without realizing it will distort the DHEA-S read.
• Insulin resistance. The metabolic and adrenal-androgen pathways are linked. Persistently high fasting insulin is associated in some studies with mildly elevated DHEA-S.

Your provider will guide the conversation based on your full medical context. These prompts are designed to keep DHEA-S in context — as one piece of a wider hormonal picture, not as a standalone verdict.

When to test, and how it's measured.

The DHEA-S test is a standard venous blood draw, typically bundled with cortisol, testosterone, SHBG and (in PCOS workups) 17-hydroxyprogesterone. No fasting is required.

Timing matters in a couple of ways. DHEA-S has much less diurnal variation than cortisol, but a morning draw — ideally between 7 and 10 a.m. — is conventional for the wider androgen and adrenal panel, since cortisol absolutely does swing across the day. Cycle day matters less for DHEA-S than for estradiol or progesterone, though many providers draw the full women's-health panel on cycle day 3 for convenience.

If you are taking DHEA supplementation — available over the counter in many U.S. pharmacies and online — mention it on the requisition. Even modest doses can push DHEA-S above the reference range, and a provider seeing a high DHEA-S without context may pursue an unnecessary workup. Many endocrinologists prefer to test off DHEA for two to four weeks if the clinical question matters.

If you are taking high-dose biotin (often in hair, skin and nail supplements), pause it for at least 48 hours before the test — biotin can interfere with several hormonal immunoassays.

Direct-to-consumer at-home tests — Function Health, LetsGetChecked, Modern Fertility's broader panels — include DHEA-S in their PCOS-aware and adrenal panels. They're useful for a baseline; they don't replace the clinical conversation. For the trade-offs across services, see our guide to at-home blood tests for women.

Related biomarkers worth understanding.

DHEA-S rarely sits alone in a thoughtful workup. The markers below come up most often alongside it.

• Testosterone — total and free. Together with DHEA-S, distinguishes ovarian from adrenal contributions to androgen excess.
• Cortisol — the other major adrenal hormone. Read alongside DHEA-S to assess HPA-axis function as a system.
• SHBG — determines how much of the androgens DHEA feeds are biologically available.
• Estradiol — relevant in perimenopause and menopause, when DHEA-derived estrone becomes a more dominant source.
• Fasting insulin — insulin resistance is a common metabolic feature in PCOS, including adrenal-predominant subtypes.
• 17-hydroxyprogesterone — used to distinguish non-classic CAH from PCOS when DHEA-S is elevated. (Heme guide coming soon.)